This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Venenum Biodesign, LLC. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: David E Kaelin, Jr: Innovator in STING Agonists
Introduction
David E Kaelin, Jr. is a notable inventor based in Helmetta, NJ (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that modulate the STING protein. His work has the potential to impact the treatment of various disorders.
Latest Patents
David E Kaelin, Jr. holds a patent for "Sting agonists." This invention provides compounds of Formula I', which are effective at modulating the STING protein. These compounds can be utilized as medicaments for treating or preventing disorders affected by the agonism of STING. He has 1 patent to his name.
Career Highlights
Kaelin is associated with Venenum Biodesign, LLC, where he continues to innovate in the field of biomedicine. His work focuses on the development of novel therapeutic agents that can enhance the body's immune response.
Collaborations
He collaborates with talented individuals such as Axel Metzger and Audrey Hospital, contributing to a dynamic research environment.
Conclusion
David E Kaelin, Jr. is a prominent figure in the field of medicinal chemistry, with a focus on STING agonists that hold promise for future medical applications. His contributions are paving the way for advancements in treatment options.